EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

A Novel Missense Variant in Ultrarare SLC35A1‐CDG Alters Cellular Glycosylation, Lipid, and Energy Metabolism Without Affecting CDG Serum Markers

Kristina Falkenstein iD, Lukas Hoeren iD, Frauke Kikul iD, Gernot Poschet iD, Christian Lüchtenborg iD, Ines B Brecht iD, Ruth Falb, Darja Gauck, Tobias Haack iD, Andreas Hecker iD, Nastassja Himmelreich iD, Jürgen G Okun iD und 2 weitere

Human Mutation · 2025

DOI: 10.1155/humu/6290620 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Human Mutation, 2025. Verfasst von Kristina Falkenstein und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric I, Center for Pediatric and Adolescent Medicine, Medical Faculty of Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Congenital Disorders of Glycosylation, Energy Metabolism, Lipid Metabolism, Mutation, Missense. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SLC35A1‐CDG is a very rare type of congenital disorders of glycosylation (CDG) with only five cases known to date. Here, we review the literature and present new data from a sixth patient carrying the uncharacterized variant c.133A>G; p.Thr45Ala in the SLC35A1 gene. In addition to known clinical symptoms of SLC35A1‐CDG, the patient presents with failure to thrive, short stature, café‐au‐lait spot, and preauricular ear tag. Even though examination of CDG markers transferrin (Tf), alpha‐1‐antitrypsin (A1AT), and apolipoprotein CIII (ApoCIII) revealed no abnormalities in serum, the patient’s fibroblasts showed significant alterations of protein expression or glycosylation of ICAM1, GP130, and TGN46 as well as differences in staining signals of lectins MAL‐I, RCAI, and SNA and deviations in LC‐MS analysis of total cellular N‐glycans. Transfection of CRISPR/Cas9 generated SLC35A1 HEK293 knockout cells with either wild‐type SLC35A1 or the c.133A>G variant restored the cellular CMP‐Neu5Ac to wild‐type levels, making a direct effect of p.Thr45Ala on the function of the transporter unlikely. Instead, our results imply that the residual transporter activity of 65% is caused by a decreased stability of the mutated SLC35A1 protein. Since O‐GlcNAcylation was affected as well, energy and lipid homeostasis were analyzed and found to be significantly altered. Notably, proliferation and glycosylation of the SLC35A1‐deficient patient fibroblasts were enhanced by supplementation of the cell culture medium with 10 mM GlcNAc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital Disorders of GlycosylationEnergy MetabolismLipid MetabolismMutation, MissenseFemaleHumansMaleBiomarkersFibroblastsGlycosylationHEK293 CellsNucleotide Transport Proteins

Stichwörter der Autor:innen

CDG-IICMP-Neu5Ac transporterGolgi sialylationSLC35A1SLC35A1-CDGcongenital disorders of glycosylationprotein instability

Substanzen

BiomarkersSLC35A1 protein, humanNucleotide Transport Proteins

Autor:innen und Institutionen

  • Pediatric I, Center for Pediatric and Adolescent Medicine, Medical Faculty of Heidelberg, Heidelberg, Germany.
  • Biochemistry Center (BZH), Heidelberg University, Heidelberg, Germany.
  • Plant Molecular Biology, Centre for Organismal Studies (COS), Heidelberg University, Heidelberg, Germany.
  • General Pediatrics Hematology/Oncology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany.
  • Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
  • Center for Rare Diseases, University of Tübingen, Tübingen, Germany.

ORCID-Profile: Kristina Falkenstein, Lukas Hoeren, Frauke Kikul, Gernot Poschet, Christian Lüchtenborg, Ines B Brecht, Tobias Haack, Andreas Hecker, Nastassja Himmelreich, Jürgen G Okun, Britta Brügger, Christian Thiel

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Falkenstein, K., Hoeren, L., Kikul, F., Poschet, G., Lüchtenborg, C., Brecht, I. B., Falb, R., Gauck, D., Haack, T., Hecker, A., Himmelreich, N., Okun, J. G., Brügger, B., & Thiel, C. (2025). A Novel Missense Variant in Ultrarare SLC35A1‐CDG Alters Cellular Glycosylation, Lipid, and Energy Metabolism Without Affecting CDG Serum Markers. Human Mutation. https://doi.org/10.1155/humu/6290620

Vancouver

Falkenstein K, Hoeren L, Kikul F, Poschet G, Lüchtenborg C, Brecht IB, et al. A Novel Missense Variant in Ultrarare SLC35A1‐CDG Alters Cellular Glycosylation, Lipid, and Energy Metabolism Without Affecting CDG Serum Markers. Human Mutation. 2025. doi:10.1155/humu/6290620

BibTeX
@article{Falkenstein2025,
  author = {Falkenstein, Kristina and Hoeren, Lukas and Kikul, Frauke and Poschet, Gernot and Lüchtenborg, Christian and Brecht, Ines B and Falb, Ruth and Gauck, Darja and Haack, Tobias and Hecker, Andreas and Himmelreich, Nastassja and Okun, Jürgen G and Brügger, Britta and Thiel, Christian},
  title = {A Novel Missense Variant in Ultrarare SLC35A1‐CDG Alters Cellular Glycosylation, Lipid, and Energy Metabolism Without Affecting CDG Serum Markers},
  journal = {Human Mutation},
  year = {2025},
  doi = {10.1155/humu/6290620}
}
Kostenlos starten →